Erector Spinae Plane Block Analgesia for Lumbar Spine Fusion Surgery
NCT ID: NCT04749095
Last Updated: 2021-02-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
45 participants
INTERVENTIONAL
2021-05-31
2021-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ultrasound Guided Erector Spinae Block for Postoperative Analgesia in Thoracotomy Patients
NCT03749395
Erector Spinae Block Versus Local Field Block in Lumbar Spine Surgeries
NCT05570565
Erector Spinae Plane Block in Spine Surgeries
NCT05247021
Postoperative Analgesia in Patients Undergoing Elective Lumbar Fusion Operations Under General Anesthesia
NCT05338320
Effectiveness of Combining Erector Spinea Block With Non Opioid Infusions as Opioid Free Anesthesia in Spine Surgeries.
NCT05850468
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Erector block
Erector spinae plane block
bilateral ESP block will be injected with 20 ml of 0.25% bupivacaine
sham block
sham subcutaneous infiltration
bilateral ESP block will be injected with 20 ml of normal saline
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Erector spinae plane block
bilateral ESP block will be injected with 20 ml of 0.25% bupivacaine
sham subcutaneous infiltration
bilateral ESP block will be injected with 20 ml of normal saline
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI less than or equal 35 kg/m2
Exclusion Criteria
* unable to give consent
* age \< 18 or \> 65
* BMI more than 35 kg/m2
* known allergy to the study medication
* coagulopathies or on anticoagulant medications
* hepatic insufficiency
* renal insufficiency
* chronic opioid use
20 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Benha University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Baher Said Elshahat Mohamed Abdelhady
Principal Investigator
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
erector spinae plane block
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.